Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Digoxin × Clear all

NCT04141995 2025-08-07

FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms